METAP2 and neoplasm: As higher MetAP2 expression was observed in tumor (mesothelioma, [39] neuroblastoma, [40] and colorectal carcinoma [41]) cells compared with normal cells, the enzyme serves as a target for anti-angiogenic compounds of natural origin, such as fumagillin and ovalicin [42].